Document Detail

Advanced Glycation End Products, Measured as Skin Autofluorescence, During Normal Pregnancy and Pregnancy Complicated by Diabetes Mellitus.
MedLine Citation:
PMID:  23113747     Owner:  NLM     Status:  Publisher    
Abstract Background: Advanced glycation end products (AGEs) accumulate with age and in diabetes mellitus (DM). AGEs can be measured by the AGE Reader (DiagnOptics Technologies BV, Groningen, The Netherlands) using skin autofluorescence (SAF). SAF is related to chronic diabetes complications. In a previous study we reported that SAF is comparable in patients with gestational DM (GDM) and controls at 27 weeks of gestation. In the current study we investigated SAF at multiple time points during pregnancy in pregnancies complicated by DM (type 1 or type 2) or GDM and in controls. Furthermore, the relation between SAF levels and adverse pregnancy outcomes was investigated. Subjects and Methods: In this single-center prospective observational study SAF was measured during pregnancy from 26 gestational weeks onward in 79 GDM patients, 21 patients with preexistent DM (type 1 or type 2), and 55 women without diabetes. Adverse pregnancy outcomes were recorded. Results: SAF decreased slightly but significantly (β=-0.018) during normal pregnancy but not in pregnancies complicated with hyperglycemia. At the end of pregnancy SAF was higher in patients with preexistent DM (1.91 arbitrary [AU] units) compared with patients with GDM (1.71 AU) or normal pregnancy (1.66 AU) but did not differ between the latter two groups. SAF was not related to adverse pregnancy outcomes. Conclusions: The decrease in SAF during normal pregnancy could be the result of physiological changes. Because SAF was not related to adverse pregnancy outcomes, it is unlikely that the AGE Reader will be of use in daily clinical practice for GDM patients as a marker for identifying high-risk pregnancy outcomes.
Wendela L de Ranitz-Greven; Lotte Kaasenbrood; Wendy K Poucki; Jeanette Hamerling; Dieuwke C Bos; Gerard H A Visser; Douwe H Biesma; Joline W J Beulens; Harold W de Valk
Related Documents :
23317507 - Metroplasty for afs class v and vi septate uterus in patients with infertility or misca...
24462327 - Cerclage retention versus removal following preterm premature rupture of membranes and ...
24249977 - Regional anesthesia in patients with pregnancy induced hypertension.
3881157 - Plasmodium falciparum malaria mimicking autoimmune hemolytic anemia during pregnancy.
21626507 - Fetal rhd genotype detection from circulating cell-free fetal dna in maternal plasma in...
8005307 - Association of time to pregnancy and the outcome of pregnancy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-31
Journal Detail:
Title:  Diabetes technology & therapeutics     Volume:  -     ISSN:  1557-8593     ISO Abbreviation:  Diabetes Technol. Ther.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-11-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100889084     Medline TA:  Diabetes Technol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 Department of Internal Medicine, University Medical Center Utrecht , Utrecht, The Netherlands .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coronal vertebral clefts: a radiological indicator for chromosomal aberrations.
Next Document:  Crystalline Polymorphs of [6,6]-Phenyl-C(61)-butyric Acid n-Butyl Ester (PCBNB).